PerkinElmer, Inc.

$ 115.24 -0.91 %

PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.

CEO: Prahlad R. Singh - https://www.perkinelmer.com

Price objectif

$166.57 44.54 %

Recommandation

Hold

DCF

$ -

Loading data...

PKI vs S&P500

Loading data...

No data available.

Quick ratio

1.41

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

41.45

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

2.78

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

3.28 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

2.89 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

-

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.47

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

4.41

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

13.37 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
2.92 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.69 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.28 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.